Results 21 to 30 of about 1,092,864 (243)

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation

open access: yesJournal of Hematology & Oncology, 2020
Synthetic lethality is a lethal phenomenon in which the occurrence of a single genetic event is tolerable for cell survival, whereas the co-occurrence of multiple genetic events results in cell death. The main obstacle for synthetic lethality lies in the
Win Topatana   +10 more
doaj   +1 more source

Synthetic lethality between TP53 and ENDOD1

open access: yesNature Communications, 2022
The authors uncover synthetic lethality between TP53 and ENDOD1, which contains an atypical endonuclease domain. Co-depleted G1 cells accumulate single stranded DNA and die.
Zizhi Tang   +11 more
doaj   +1 more source

Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors [PDF]

open access: yes, 2017
In BRCA2-defective cells, poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors can trigger synthetic lethality, as two independent DNA-repairing mechanisms are simultaneously impaired. Here, we have pharmacologically induced synthetic lethality,
Minucci S.   +14 more
core   +3 more sources

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency

open access: yesCommunications Biology, 2021
Bajrami, Walker et al. investigated the synthetic lethality between BRCA gene defects and inhibition of two sirtuin genes, SIRT1 or SIRT6, which was found to be associated with replication stress and increased PARylation.
Ilirjana Bajrami   +11 more
doaj   +1 more source

Breast Cancer Predisposition Genes and Synthetic Lethality

open access: yes, 2021
BRCA1 and BRCA2 are tumor suppressor genes with pivotal roles in the development of breast and ovarian cancers. These genes are essential for DNA double-strand break repair via homologous recombination (HR), which is a virtually error-free DNA repair ...
Hannah E. Neiger   +2 more
core   +1 more source

Protocol for Comprehensive Synthetic Lethality Screens

open access: yesSTAR Protocols, 2020
Summary: Here, we provide a detailed protocol for synthetic lethality screens in a Jurkat T cell leukemia line using cell death as the readout measuring the combinatorial effect of a pan-PI3K inhibitor (GDC0941) with specific gene depletion by shRNA.
Damia Romero-Moya, Jeroen P. Roose
doaj   +1 more source

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma

open access: yesCell Death Discovery, 2022
Many genes responsible for Malignant mesothelioma (MM) have been identified as tumor suppressor genes and it is difficult to target these genes directly at a molecular level.
Koya Suzuki   +14 more
doaj   +1 more source

Overview of Ferroptosis and Synthetic Lethality Strategies

open access: yes, 2021
Ferroptosis, a term first proposed in 2012, is iron-dependent, non-apoptotic regulatory cell death induced by erastin. Ferroptosis was originally discovered during synthetic lethal screening for drugs sensitive to RAS mutant cells, and is closely related
Susumu Kirimura   +5 more
core   +1 more source

Modeling synthetic lethality [PDF]

open access: yes, 2008
International audienceBACKGROUND: Synthetic lethality defines a genetic interaction where the combination of mutations in two or more genes leads to cell death.
Nolwenn Le Meur   +3 more
core   +1 more source

Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells

open access: yesActa Pharmaceutica Sinica B, 2020
Breast cancer susceptibility gene 1 (BRCA1) is a tumor suppressor gene, which is frequently mutated in breast and ovarian cancers. BRCA1 plays a key role in the homologous recombination directed DNA repair, allowing its deficiency to act as a therapeutic
Baoyuan Zhang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy